ImmunoPrecise Antibodies Ltd. (IPA) to report earnings for July 31, 2024, with expected $-0.09 EPS.

From Nasdaq: 2024-09-13 16:00:01

ImmunoPrecise Antibodies Ltd. (IPA) is set to report earnings for the quarter ending July 31, 2024. The consensus earnings per share forecast is $-0.09, marking an 18.18% increase from last year. IPA missed earnings in the 2nd quarter by -420%. The 2025 Price to Earnings ratio is -2.56, lower than the industry average of 21.10.



Read more at Nasdaq:: Pre-Market Earnings Report for September 16, 2024 : IPA